Oral squamous carcinomas (SCCs) account for 4% of all new cancers and about 2% of cancer deaths annually in the U.S. These cancers affect speech, swallowing, cosmetic appearance, and factors that detract from the quality of life. Despite advances in therapy, no significant improvement in oral cancer survival has occurred in the past 30 years. Progress towards reducing the incidence, morbidity, and mortality of oral SCCs will require a three-tiered approach: identification of the molecular factors that contribute to the initiation and progression, elucidation of the host and tumor characteristics associated with the progression and the development of novel approaches for the treatment of premalignant and microinvasive oral SCCs. Because of its location and extensive referral pattern, the University of Texas M.D. Anderson Cancer Center treats a large number of patients throughout the spectrum of oral SCCs, including oral premalignancies, early stage and advanced stage SCCs.
The specific aims of this Center are to: (1) develop an understanding of the molecular events leading to the initiation of oral SCCs; (2) ascertain the contribution of genetic mutations and the induction of degradative enzymes in the early invasion of oral SCCs; (3) develop novel biologic and molecular therapeutic intervention strategies for premalignant and microinvasive oral SCCs; (4) develop effective educational programs for screening and community awareness of prevention strategies for oral cancers. These goals will be addressed by 14 key investigators in basic science, pathology, and transitional clinical investigations. The work to be undertaken includes: (1) molecular markers for diagnostic and biological assessment of premalignancy of oral SCCs; (2) degradative enzymes in microinvasive and early invasive SCC; (3) modulation of cell differentiation, growth, and apoptosis in premalignant and microinvasive oral SCCs, and (4) apoptosis-inducing gene therapy for oral premalignancies. Additionally, two developmental projects will investigate inherited errors in carcinogen metabolism and tissue fluorescence as a non-interventional screening diagnostic tool in early oral SCCs. These studies will be coordinated and supported by three cores devoted to oral cancer research, administration and education; tissue procurement, maintenance, processing, and distribution of clinical samples; and, biostatistical analysis and integration of laboratory, clinical and epidemiological data. These efforts will be supported by program advisers composing an Internal Advisory Committee and an External Advisory Committee. The Oral Cancer Research Center will thus provide new information on the etiology, biology, initiation, progression and treatment of oral SCCs.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Specialized Center (P50)
Project #
3P50DE011906-04S1
Application #
6335777
Study Section
Special Emphasis Panel (ZDE1 (13))
Program Officer
Sandberg, Ann
Project Start
1996-09-30
Project End
2001-07-31
Budget Start
1999-08-01
Budget End
2000-07-31
Support Year
4
Fiscal Year
2000
Total Cost
$2,975
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Surgery
Type
Other Domestic Higher Education
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Wang, Heng; Hicks, John; Khanbolooki, Parham et al. (2003) Transgenic mice demonstrate novel promoter regions for tissue-specific expression of the urokinase receptor gene. Am J Pathol 163:453-64
Gonzalez, Hernan E; Gujrati, Manu; Frederick, Mitchell et al. (2003) Identification of 9 genes differentially expressed in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 129:754-9
Jayakumar, Arumugam; Kang, Ya'an; Frederick, Mitchell J et al. (2003) Inhibition of the cysteine proteinases cathepsins K and L by the serpin headpin (SERPINB13): a kinetic analysis. Arch Biochem Biophys 409:367-74
Chun, Kyung-Hee; Benbrook, Doris M; Berlin, K Darrell et al. (2003) The synthetic heteroarotinoid SHetA2 induces apoptosis in squamous carcinoma cells through a receptor-independent and mitochondria-dependent pathway. Cancer Res 63:3826-32
Higuchi, Eisaku; Chandraratna, Roshantha A S; Hong, Waun K et al. (2003) Induction of TIG3, a putative class II tumor suppressor gene, by retinoic acid in head and neck and lung carcinoma cells and its association with suppression of the transformed phenotype. Oncogene 22:4627-35
Liu, Yanna; Li, Jun Z; Yuan, Xiao H et al. (2002) An AP-1 binding site mutation in HPV-16 LCR enhances E6/E7 promoter activity in human oral epithelial cells. Virus Genes 24:29-37
Yan, Chunhong; Wang, Heng; Boyd, Douglas D (2002) ATF3 represses 72-kDa type IV collagenase (MMP-2) expression by antagonizing p53-dependent trans-activation of the collagenase promoter. J Biol Chem 277:10804-12
El-Naggar, Adel K; Kim, Hyung W; Clayman, Gary L et al. (2002) Differential expression profiling of head and neck squamous carcinoma: significance in their phenotypic and biological classification. Oncogene 21:8206-19
Shin, M; Yan, C; Boyd, D (2002) An inhibitor of c-jun aminoterminal kinase (SP600125) represses c-Jun activation, DNA-binding and PMA-inducible 92-kDa type IV collagenase expression. Biochim Biophys Acta 1589:311-6
Hayashi, K; Yokozaki, H; Naka, K et al. (2001) Overexpression of retinoic acid receptor beta induces growth arrest and apoptosis in oral cancer cell lines. Jpn J Cancer Res 92:42-50

Showing the most recent 10 out of 57 publications